ZVRA icon

Zevra Therapeutics
ZVRA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$24
182% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Sumant Kulkarni
50% 1-yr ZVRA win rate
6 Nov ‘25 24 days ago
Cantor Fitzgerald
Cantor Fitzgerald
Kristen Kluska
25% 1-yr ZVRA win rate
6 Nov ‘25 25 days ago